July 31st 2026
Argenx pens $2.2bn deal to buy autoimmune biotech Forte
July 24th 2026
Akums To Acquire Oriflame India’s Manufacturing Business
July 17th 2026
Oxford begins first human trial of Bundibugyo Ebola vaccine
July 10th 2026
Novartis to acquire UK-based Myricx Bio for up to $1.5 billion
July 3rd 2026
Hyperfine launches
next-generation Swoop MRI
system in Europe
Health & Pharma News
Archive
Archive
July 31st 2026
Argenx pens $2.2bn deal to buy autoimmune biotech Forte
July 24th 2026
Akums To Acquire Oriflame India’s Manufacturing Business
July 17th 2026
Oxford begins first human trial of Bundibugyo Ebola vaccine
July 10th 2026
Novartis to acquire UK-based Myricx Bio for up to $1.5 billion
July 3rd 2026
Hyperfine launches
next-generation Swoop MRI
system in Europe